Computed tomography (CT)-defined sarcopenia and myosteatosis are prevalent in patients with neuroendocrine neoplasms (NENs) treated with peptide receptor radionuclide therapy (PRRT)
David Chan, Stephen Clarke, Alexander Engel, Connie I. Diakos, Nick Pavlakis, Paul Roach, Dale L. Bailey, Judith Bauer, Merran Findlay
Topics & Concepts
SarcopeniaMedicineRadionuclide therapyInternal medicineClinical endpointRetrospective cohort studyNeuroendocrine tumorsGastroenterologyClinical trialNeuroendocrine Tumor Research AdvancesNutrition and Health in AgingMetastasis and carcinoma case studies